In this webinar, hosted by DDW and supported by Thermo Fisher Scientific, you will learn about the current advancements taking place in antibiotic drug discovery.

This event will highlight how cryo-electron microscopy (cryo-EM) can be used to target the lipopolysaccharide transporter MsbA in multidrug-resistant Acinetobacter baumannii. This pathogen is a major cause of severe infections in intensive care units, and our novel approach offers promising solutions to combat this threat.

The webinar will take place on Wednesday 11 December 2024 at 7am PST, 10am EST, 3pm GMT, 4pm CET.

The talk will be delivered by Daniel J Klein, Senior Director, Protein & Structural Chemistry, Merck & Co., Inc., Rahway, NJ, USA. Dr Klein has over 15 years of pharmaceutical industry experience leading research teams in structure-based molecular design for therapeutic discovery.

You will learn:

  • About innovative approaches to antibiotic drug discovery
  • How cryo-EM can be used to study membrane protein transporters
  • How human serum albumin crystal structures are used for lead optimisation

A live Q&A session with the speaker follows the presentation.

Register for free now to secure your place.